ELV vs EOLS · P/E 18, rev $199.13B vs rev $266.3M
Elevance Health Inc (ELV) versus Evolus Inc (EOLS) — a side-by-side from cached financials, not a winner call.
Elevance Health Inc (ELV) is a healthcare plans company listed on US.
Evolus Inc (EOLS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported ELV revenue for 2025-12-31 was $199.13B. Net income was $5.66B. Revenue was up 12.5% from 2024-12-31 to 2025-12-31. ELV currently screens at market cap $90.24B and trailing P/E 17.6.
Latest reported EOLS revenue for 2024-12-31 was $266.3M. Net income was -$50.4M. Revenue was up 31.8% from 2023-12-31 to 2024-12-31. EOLS currently screens at market cap $597.0M.
ELV currently screens at market cap $90.24B and trailing P/E 17.6. EOLS currently screens at market cap $597.0M.
Not investment advice. Open the ELV and EOLS stock pages for the full models.
Not investment advice.